AUSTEDO XR® (deutetrabenazine) extended-release
Teva is dedicated to providing educational resources for providers, patients, & caregivers. Determined to meet that goal, this channel hosts informative videos about tardive dyskinesia (TD), chorea associated with Huntington's disease (HD), & AUSTEDO XR.
Subscribe to stay updated with information about AUSTEDO XR.
IMPORTANT SAFETY INFORMATION
Depression & Suicidality in HD Patients: AUSTEDO XR can increase the risk of depression & suicidal thoughts & behavior (suicidality) in HD patients. Balance the risks of depression & suicidality with the clinical need for treatment of chorea. Closely monitor patients for the emergence or worsening of depression, suicidality, or unusual changes in behavior. Inform patients, their caregivers, & families of the risk of depression & suicidality & instruct them to report behaviors of concern promptly to the treating physician.
Please see full Prescribing Information, including Boxed Warning, below.
©2025 Teva Neuroscience, Inc. AUS-47929 June 2025
Patient & Caregiver Testimonial Video: James and Sue
What Could Movement Reduction Mean for Your Patients?
Movement Control Made Possible: Rachel's Journey With TD and Schizophrenia
6 Years of Symptom Control: Joe's Journey With TD Treatment
What Could Movement Reduction Mean for Your Patients?
Progressive HD Chorea: A Case Study of Care and Treatment Presented by Danny Bega, MD
The Importance of TD Education
Hear About TD From an NP Who Lived It
Patient Testimonial Video | Denise's Story (Chapter 1)
AUSTEDO XR Daughter Knows Best: 60 TV Commercial
AUSTEDO XR Spouse Knows Best: 60 TV Commercial
OLV HD Pilot–Authentic Answers: 60 OLV
Patient Testimonial Video | Joe's Story (Chapter 1)
Patient Testimonial Video | Rachel's Story (Chapter 1)
Easing the Burden for Patients and Caregivers Nathan & Heather's Story
The Impact of TD: TD Impact
The Impact of TD: Multiple Impacts
TD: Mechanism of Disease